Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...
Tác giả chính: | White, N |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2013
|
Những quyển sách tương tự
-
Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
Bằng: Banda, CG, et al.
Được phát hành: (2024) -
Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
Bằng: Kloprogge, F
Được phát hành: (2013) -
Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
Bằng: Tarning, J, et al.
Được phát hành: (2014) -
Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
Bằng: Tarning, J, et al.
Được phát hành: (2014) -
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
Bằng: White, N
Được phát hành: (1997)